Loading clinical trials...
Loading clinical trials...
Tovorafenib for the Treatment of Newly Diagnosed or Recurrent Craniopharyngioma in Children and Young Adults
Conditions
Interventions
Tovorafenib
Locations
20
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Rady Children's Hospital/University of California, San Diego
San Diego, California, United States
University of California, San Francisco
San Francisco, California, United States
University of Florida
Gainesville, Florida, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana, United States
Start Date
September 12, 2022
Primary Completion Date
March 1, 2027
Completion Date
March 1, 2028
Last Updated
April 23, 2026
NCT05233397
NCT06970145
NCT06801756
NCT07316101
NCT02842723
NCT06217848
Lead Sponsor
Sabine Mueller, MD, PhD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions